Veterinary Anti Infectives Market Size, Share, Analysis 2031
Veterinary Anti Infectives Market Size, Share, Analysis 2031
Segments - Veterinary Anti-infectives Market by Animal Types (Cattles, Poultry, Cats, Dogs, and Others), Product Types (Antibacterial, Antivirals, Antifungals, and Others), Mode of Administration (Orals, Topical, and Others), and Regions (Asia Pacific, North America, Latin America, Europe, and Middle East & Africa) – Global Industry Analysis, Growth, Share, Size, Trends, and Forecast 2023 –2031
Upcoming
| Report ID :HC-3318
| 4.4 Rating
| 64 Reviews
| 218 Pages
| Format :
Report Description
Veterinary Anti-infectives Market Outlook
The global veterinary anti-infectives market size was valued at USD 6.64 Billion in 2022 and is likely reach to USD 11.60 Billion by 2031, expanding at a CAGR of 6.4% during the forecast period, 2023-2031. The growth of the market is attributed to increasing incidence of zoonotic and foodborne diseases.
Anti-infectives are used for both prevention as well as curative diseases. They are also administered to prevent infectious agents.
The COVID-19 pandemic has negatively impacted the animal health industry, weakened the supply chain, created shortage of animal health products such as nutritional feed as well as vaccines, and manufacturers in the animal health industry were left with a significantly reduced workforce. However, the growing focus on animal health and relaxation in restriction is positively influencing the market growth.
Market Trends, Drivers, Restraints, and Opportunities
- Increasing pet ownership and soaring demand for improved nutrition, especially functional animal protein, is anticipated to drive the market growth during the forecast period.
- Rising widened focus on food safety is estimated to spur the market growth in the coming years.
- Growing affordability of therapeutics and increasing consumer awareness for pet care and livestock offer are projected to boost the market growth in the coming years.
- Expanding pet insurance services is anticipated to drive the market growth during the forecast period.
- Increasing incidence of infectious disease is estimated to spur the market growth in the coming years.
- Growing requirement for the precautionary measures and the treatment is projected to boost the market growth in the coming years.
- Increasing demand for animal products such as meat and milk is anticipated to drive the market growth during the forecast period.
- High cost of animal testing and veterinary services is estimated to restrict the market growth.
- Growing biologics and specialty care offer has led to new opportunities in the market.
- Improvisation in research and development and product innovation in areas such as biologics and specialty care can create lucrative opportunities in the market.
Scope of Veterinary Anti-infectives Market Report
The report on the global veterinary anti-infectives market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.
|
Attributes |
Details |
|
Report Title |
Veterinary Anti-infectives Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast |
|
Base Year |
2022 |
|
Historic Data |
2016–2021 |
|
Forecast Period |
2023–2031 |
|
Segmentation |
Animal Types (Cattles, Poultry, Cats, Dogs, and Others), Product Types (Antibacterial, Antivirals, Antifungals, and Others), and Mode of Administration (Orals, Topical, and Others) |
|
Regional Scope |
Asia Pacific, North America, Latin America, Europe, and Middle East & Africa |
|
Report Coverage |
Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast |
|
Key Players Covered in the Report |
Bayer AG; Boehringer Ingelheim GmbH; Ceva Sante Animale; Elanco; Merck & Co Inc.; Phibro Animal Health Corporation; Vetoquinol S.A.; Virbac; and Zoetis Inc. |
Veterinary Anti-infectives Market Segment Insights
Cattles segment to hold a significant market share
On the basis of animal types, the market is divided into cattles, poultry, cats, dogs, and others. The poultry segment is expected to hold a key share of the market in the coming years owing to increasing consumption of meat.
However, the cattles segment is anticipated to expand at a rapid pace during the forecast period due to high population of cattle across the world and the dominance of cattle farming as a major income source for people.
Antivirals segment is projected to expand at a considerable CAGR
Based on product types, the market is segregated into antibacterial, antivirals, antifungals, and others. The antibacterial segment is expected to hold a key share of the market in the coming years owing to increasing number of bacterial infections in livestock.
On the other hand, the antivirals segment is anticipated to expand at a robust rate during the forecast period due to rising demand in the market as pets are prone to viral infections.
Topical segment is projected to grow at a rapid pace
On the basis of mode of administrations, the market is segregated into orals, topical, and others. The orals segment is expected to hold a key share of the market during the forecast period, as they can be easily deployed in food.
On the other hand, the topical segment is anticipated to expand at a rapid pace during the forecast period, as they are used for local treatment of skin, to of external and internal parasites, and transdermal delivery of therapeutic agents.
North America is estimated to account a major market share
In terms of regions, the market is classified as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. North America is expected to constitute a significant share of the market during the projected period owing to increasing usage of veterinary anti-infectives.
However, the market of Asia Pacific is anticipated expand at a rapid pace during the forecast period due to increasing awareness among common people regarding the benefits od using veterinary anti-infectives.
Segments
Animal Types
- Cattles
- Poultry
- Cats
- Dogs
- Others
Product Types
- Antibacterial
- Antivirals
- Antifungals
- Others
Mode of Administration
- Orals
- Topical
- Others
Regions
- Asia Pacific
- North America
- Latin America
- Europe
- Middle East & Africa
Key Players
- Bayer AG
- Boehringer Ingelheim GmbH
- Ceva Sante Animale
- Elanco
- Merck & Co Inc.
- Phibro Animal Health Corporation
- Vetoquinol S.A.
- Virbac
- Zoetis Inc.
Competitive Landscape
Key players competing in the global veterinary anti-infectives market includes Bayer AG; Boehringer Ingelheim GmbH; Ceva Sante Animale; Elanco; Merck & Co Inc.; Phibro Animal Health Corporation; Vetoquinol S.A.; Virbac; and Zoetis Inc.
Some of these players are engaging in business strategies such as mergers, acquisitions, partnerships, collaborations, capacity expansion, and product launches to enhance their market share.
Table Of Content
1. Executive Summary2. Assumptions and Acronyms Used
3. Research Methodology
4. Veterinary Anti-infectives Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Veterinary Anti-infectives Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Veterinary Anti-infectives Market - Supply Chain
4.5. Global Veterinary Anti-infectives Market Forecast
4.5.1. Veterinary Anti-infectives Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Veterinary Anti-infectives Market Size (000’ Units) and Y-o-Y Growth
4.5.3. Veterinary Anti-infectives Market Absolute $ Opportunity
5. Global Veterinary Anti-infectives Market Analysis and Forecast by Region
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Region
5.2.2. Y-o-Y Growth Projections by Region
5.3. Veterinary Anti-infectives Market Size and Volume Forecast by Region
5.3.1. North America
5.3.2. Latin America
5.3.3. Europe
5.3.4. Asia Pacific
5.3.5. Middle East and Africa (MEA)
5.4. Absolute $ Opportunity Assessment by Region
5.5. Market Attractiveness/Growth Potential Analysis by Region
5.6. Global Veterinary Anti-infectives Demand Share Forecast, 2019-2026
6. North America Veterinary Anti-infectives Market Analysis and Forecast
6.1. Introduction
6.1.1. Basis Point Share (BPS) Analysis by Country
6.1.2. Y-o-Y Growth Projections by Country
6.2. North America Veterinary Anti-infectives Market Size and Volume Forecast by Country
6.2.1. U.S.
6.2.2. Canada
6.3. Absolute $ Opportunity Assessment by Country
6.4. Market Attractiveness/Growth Potential Analysis
6.4.1. By Country
6.4.2. By Product Type
6.4.3. By Application
6.5. North America Veterinary Anti-infectives Demand Share Forecast, 2019-2026
7. Latin America Veterinary Anti-infectives Market Analysis and Forecast
7.1. Introduction
7.1.1. Basis Point Share (BPS) Analysis by Country
7.1.2. Y-o-Y Growth Projections by Country
7.1.3. Latin America Average Pricing Analysis
7.2. Latin America Veterinary Anti-infectives Market Size and Volume Forecast by Country
7.2.1. Brazil
7.2.2. Mexico
7.2.3. Rest of Latin America
7.3. Absolute $ Opportunity Assessment by Country
7.4. Market Attractiveness/Growth Potential Analysis
7.4.1. By Country
7.4.2. By Product Type
7.4.3. By Application
7.5. Latin America Veterinary Anti-infectives Demand Share Forecast, 2019-2026
8. Europe Veterinary Anti-infectives Market Analysis and Forecast
8.1. Introduction
8.1.1. Basis Point Share (BPS) Analysis by Country
8.1.2. Y-o-Y Growth Projections by Country
8.1.3. Europe Average Pricing Analysis
8.2. Europe Veterinary Anti-infectives Market Size and Volume Forecast by Country
8.2.1. Germany
8.2.2. France
8.2.3. Italy
8.2.4. U.K.
8.2.5. Spain
8.2.6. Russia
8.2.7. Rest of Europe
8.3. Absolute $ Opportunity Assessment by Country
8.4. Market Attractiveness/Growth Potential Analysis
8.4.1. By Country
8.4.2. By Product Type
8.4.3. By Application
8.5. Europe Veterinary Anti-infectives Demand Share Forecast, 2019-2026
9. Asia Pacific Veterinary Anti-infectives Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.1.3. Asia Pacific Average Pricing Analysis
9.2. Asia Pacific Veterinary Anti-infectives Market Size and Volume Forecast by Country
9.2.1. China
9.2.2. Japan
9.2.3. South Korea
9.2.4. India
9.2.5. Australia
9.2.6. Rest of Asia Pacific (APAC)
9.3. Absolute $ Opportunity Assessment by Country
9.4. Market Attractiveness/Growth Potential Analysis
9.4.1. By Country
9.4.2. By Product Type
9.4.3. By Application
9.5. Asia Pacific Veterinary Anti-infectives Demand Share Forecast, 2019-2026
10. Middle East & Africa Veterinary Anti-infectives Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Middle East & Africa Average Pricing Analysis
10.2. Middle East & Africa Veterinary Anti-infectives Market Size and Volume Forecast by Country
10.2.1. Saudi Arabia
10.2.2. South Africa
10.2.3. UAE
10.2.4. Rest of Middle East & Africa (MEA)
10.3. Absolute $ Opportunity Assessment by Country
10.4. Market Attractiveness/Growth Potential Analysis
10.4.1. By Country
10.4.2. By Product Type
10.4.3. By Application
10.5. Middle East & Africa Veterinary Anti-infectives Demand Share Forecast, 2019-2026
11. Competition Landscape
11.1. Global Veterinary Anti-infectives Market: Market Share Analysis
11.2. Veterinary Anti-infectives Distributors and Customers
11.3. Veterinary Anti-infectives Market: Competitive Dashboard
11.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
Methodology
Related Reports
Some other reports from this category!
Our Clients
